Exablate Procedure for Advanced Parkinson's Disease

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Recruiting Observational Study
Movement Disorders Neurology Parkinsons Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 99
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
InSightec · Industry
Who this trial is looking for

This trial is looking for people aged 30 and older with advanced Parkinson's disease who have motor complications and are planning to receive the Exablate procedure. Participants will need to visit the registry for follow-ups at 3, 6, and 12 months, and then every year for 5 years.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 30 years old or older.
  • I have been diagnosed with Parkinson's disease.
  • I have motor complications that are not controlled by medications.
  • I am planning to have the Exablate procedure.
  • I am willing to follow the registry requirements and attend all visits.
  • I have signed and received a copy of the informed consent form.

You may not be able to join if

  • I do not agree to participate in the registry.
  • I am unlikely to participate for the entire duration of the registry.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men and women, age 30 years and older. * Subject undergoing a planned an Exablate procedure for their Parkinson's Disease with Motor Complications per local institution standard of care. * Subject is willing to cooperate with the Registry requirements including compliance with…
Contacts

Kingsley Nwaogu

2143048265

clinicalresearchquestions@insightec.com

CONTACT

Julia Zhu

2148462577

clinicalresearchquestions@insightec.com

CONTACT